Source:http://linkedlifedata.com/resource/pubmed/id/20415904
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2010-4-26
|
| pubmed:abstractText |
Right lobe living donor liver transplantation is an effective treatment for selected individuals with end-stage liver disease. Although 1 year donor morbidity and mortality have been reported, little is known about outcomes beyond 1 year. Our objective was to analyze the outcomes of the first 202 consecutive donors performed at our center with a minimum follow-up of 12 months (range 12-96 months). All physical complications were prospectively recorded and categorized according to the modified Clavien classification system. Donors were seen by a dedicated family physician at 2 weeks, 1, 3 and 12 months postoperatively and yearly thereafter. The cohort included 108 males and 94 females (mean age 37.3 +/- 11.5 years). Donor survival was 100%. A total of 39.6% of donors experienced a medical complication during the first year after surgery (21 Grade 1, 27 Grade 2, 32 Grade 3). After 1 year, three donors experienced a medical complication (1 Grade 1, 1 Grade 2, 1 Grade 3). All donors returned to predonation employment or studies although four donors (2%) experienced a psychiatric complication. This prospective study suggests that living liver donation can be performed safely without any serious late medical complications and suggests that long-term follow-up may contribute to favorable donor outcomes.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1600-6143
|
| pubmed:author |
pubmed-author:AbbeySS,
pubmed-author:AdcockLL,
pubmed-author:CattralM SMS,
pubmed-author:DubayDD,
pubmed-author:GirgrahNN,
pubmed-author:GrantD RDR,
pubmed-author:GreigP DPD,
pubmed-author:HoltzmanSS,
pubmed-author:KashfiAA,
pubmed-author:LiewS HSH,
pubmed-author:LillyLL,
pubmed-author:MacleodCC,
pubmed-author:McGilvrayII,
pubmed-author:RennerE LEL,
pubmed-author:SelznerMM,
pubmed-author:SelznerNN,
pubmed-author:SmithRR,
pubmed-author:TherapondosGG
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
364-71
|
| pubmed:meshHeading |
pubmed-meshheading:20415904-Adult,
pubmed-meshheading:20415904-Female,
pubmed-meshheading:20415904-Humans,
pubmed-meshheading:20415904-Liver,
pubmed-meshheading:20415904-Liver Failure,
pubmed-meshheading:20415904-Liver Transplantation,
pubmed-meshheading:20415904-Living Donors,
pubmed-meshheading:20415904-Male,
pubmed-meshheading:20415904-Morbidity,
pubmed-meshheading:20415904-Prospective Studies,
pubmed-meshheading:20415904-Tissue Donors,
pubmed-meshheading:20415904-Treatment Outcome,
pubmed-meshheading:20415904-Universities
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience.
|
| pubmed:affiliation |
Liver Transplant Program, Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
|
| pubmed:publicationType |
Journal Article
|